| Gilead Sciences, Inc. | 20,426 | US$2.58M | 5.5% |
| Vertex Pharmaceuticals Incorporated | 5,002 | US$2.48M | 5.3% |
| Astrazeneca Plc | 11,394 | US$2.16M | 4.6% |
| Roivant Sciences Ltd. | 48,355 | US$1.71M | 3.7% |
| Argenx Se | 1,806 | US$1.68M | 3.6% |
| Neurocrine Biosciences, Inc. | 9,727 | US$1.64M | 3.5% |
| Incyte Corporation | 14,451 | US$1.64M | 3.5% |
| Axsome Therapeutics, Inc. | 6,531 | US$1.6M | 3.4% |
| Apogee Therapeutics, Inc. | 11,533 | US$1.53M | 3.3% |
| Ionis Pharmaceuticals, Inc. | 15,430 | US$1.22M | 2.6% |
| Ascendis Pharma A/s | 4,585 | US$1.22M | 2.6% |
| Insmed Incorporated | 11,394 | US$1.21M | 2.6% |
| Protagonist Therapeutics, Inc. | 9,171 | US$1.12M | 2.4% |
| Personalis, Inc. | 78,924 | US$1.06M | 2.3% |
| Rhythm Pharmaceuticals, Inc. | 9,449 | US$1.05M | 2.2% |
| Abbvie Inc. | 3,613 | US$909K | 1.9% |
| Jazz Pharmaceuticals Plc | 3,613 | US$871K | 1.9% |
| Amgen Inc. | 2,362 | US$855K | 1.8% |
| Biogen Inc. | 3,891 | US$841K | 1.8% |
| Catalyst Pharmaceuticals, Inc. | 23,622 | US$742K | 1.6% |
| Halozyme Therapeutics, Inc. | 9,426 | US$738K | 1.6% |
| Meiragtx Holdings Plc | 54,469 | US$736K | 1.6% |
| Krystal Biotech, Inc. | 1,945 | US$723K | 1.5% |
| Nuvalent, Inc. | 5,558 | US$686K | 1.5% |
| Abivax Sa | 5,141 | US$685K | 1.5% |
| Edgewise Therapeutics, Inc. | 15,840 | US$644K | 1.4% |
| Nurix Therapeutics, Inc. | 25,845 | US$627K | 1.3% |
| Sanofi Sa | 7,322 | US$622K | 1.3% |
| Oruka Therapeutics, Inc. | 6,531 | US$622K | 1.3% |
| Kymera Therapeutics, Inc. | 5,385 | US$617K | 1.3% |
| Spyre Therapeutics, Inc. | 6,670 | US$592K | 1.3% |
| Agios Pharmaceuticals, Inc. | 14,173 | US$526K | 1.1% |
| Newamsterdam Pharma Company N.v. | 14,868 | US$504K | 1.1% |
| Cytokinetics, Incorporated | 5,697 | US$485K | 1.0% |
| Celldex Therapeutics, Inc. | 12,784 | US$476K | 1.0% |
| Trevi Therapeutics, Inc. | 24,317 | US$454K | 0.97% |
| Alnylam Pharmaceuticals, Inc. | 1,390 | US$418K | 0.90% |
| Veracyte, Inc. | 6,948 | US$408K | 0.87% |
| Candel Therapeutics, Inc. | 36,683 | US$378K | 0.81% |
| Natera, Inc. | 1,390 | US$377K | 0.81% |
| Rezolute, Inc. | 72,255 | US$376K | 0.81% |
| Cullinan Therapeutics, Inc. | 20,426 | US$372K | 0.80% |
| Crinetics Pharmaceuticals, Inc. | 9,866 | US$369K | 0.79% |
| Xeris Biopharma Holdings, Inc. | 46,549 | US$369K | 0.79% |
| Design Therapeutics, Inc. | 21,537 | US$312K | 0.67% |
| Monte Rosa Therapeutics, Inc. | 12,645 | US$306K | 0.66% |
| Disc Medicine, Inc. | 4,030 | US$295K | 0.63% |
| Rapport Therapeutics, Inc. | 6,531 | US$272K | 0.58% |
| Arvinas, Inc. | 30,622 | US$254K | 0.55% |
| Icon Plc | 1,390 | US$241K | 0.52% |
| Tectonic Therapeutic, Inc. | 6,948 | US$239K | 0.51% |
| Sionna Therapeutics, Inc. | 4,863 | US$214K | 0.46% |
| Wave Life Sciences Ltd. | 35,670 | US$207K | 0.44% |
| Intellia Therapeutics, Inc. | 11,672 | US$197K | 0.42% |
| Atrium Therapeutics, Inc. | 13,478 | US$181K | 0.39% |
| Iqvia Holdings, Inc. | 834 | US$161K | 0.35% |
| Annexon, Inc. | 24,872 | US$142K | 0.30% |
| Adma Biologics Inc | 10,143 | US$84,897 | 0.18% |
| Aldeyra Therapeutics, Inc. | 37,656 | US$80,207 | 0.17% |
| Mdxhealth Sa | 0 | US$0 | 0.00% |
| Avalo Therapeutics, Inc. | 0 | US$0 | 0.00% |